Crossmark

Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway

Crossref DOI link: https://doi.org/10.1038/s41598-020-57603-9

Published Online: 2020-01-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Murai, Kazuhiro

Hikita, Hayato

Kai, Yugo

Kondo, Yasuteru https://orcid.org/0000-0001-5935-4346
Fukuoka, Makoto

Fukutomi, Keisuke

Doi, Akira

Yamai, Takuo

Nakabori, Tasuku

Fukuda, Ryo

Takahashi, Takeshi

Miyakawa, Kei

Suemizu, Hiroshi https://orcid.org/0000-0002-3706-2454
Ryo, Akihide

Yamada, Ryoko

Kodama, Takahiro https://orcid.org/0000-0002-6250-1324
Sakamori, Ryotaro https://orcid.org/0000-0002-1580-607X
Tatsumi, Tomohide

Takehara, Tetsuo
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (JP19fk0310108)

Japan Agency for Medical Research and Development (JP19fk0210021)

Japan Agency for Medical Research and Development (JP19fk0310108)

Japan Agency for Medical Research and Development (JP19fk0310108)

Japan Agency for Medical Research and Development (JP19fk0210021)

Japan Agency for Medical Research and Development (JP19fk0310103)

Japan Agency for Medical Research and Development (JP19fk0210021)

Japan Agency for Medical Research and Development (JP19fk0310108)

Japan Agency for Medical Research and Development (JP19fk0310108)

Japan Agency for Medical Research and Development (JP19fk0210021)
License Information

Text and Data Mining valid from 2020-01-22

Version of Record valid from 2020-01-22
More Information

Article History

Received: 16 July 2019

Accepted: 3 January 2020

First Online: 22 January 2020

Competing interests

: Tetsuo Takehara received research grants and lecture fees from Bristol-Myers Squibb. Hayato Hikita received research grants from Bristol-Myers Squibb. Other authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below